EUVIMEDEUVIMED entdecken
Open Access

The signature of circulating microparticles in heart failure patients with metabolic syndrome

Alexander E Berezin, Alexander Kremzer, Tatyana Berezina, Yu Martovitskaya

Journal of Circulating Biomarkers · 2016

DOI: 10.1177/1849454416663659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Circulating Biomarkers, 2016. Verfasst von Alexander E Berezin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Consultant of the Therapeutic Unit, Internal Medicine Department, State Medical University, Zaporozhye, Ukraine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of pattern of circulating endothelial cell-derived microparticles, platelet-derived microparticles (PMPs), and monocyte-derived microparticles (MMPs) in metabolic syndrome (MetS) patients with chronic heart failure (CHF) is not still understood. The aim of the study was to investigate a pattern of circulating microparticles (MPs) in MetS patients with CHF in relation to neurohumoral and inflammatory activation. The study retrospectively involved 101 patients with MetS and 35 healthy volunteers. Biomarkers were measured at baseline of the study. The results of the study have shown that numerous circulating PMPs- and MMPs in subjects with MetS (with or without CHF) insufficiently distinguished from level obtained in healthy volunteers. We found elevated level of CD31+/annexin V+ MPs in association with lower level of CD62E+ MPs. Therefore, we found that biomarkers of biomechanical stress serum N-terminal brain natriuretic peptide and inflammation (high-sensitive C-reactive protein ,osteoprotegerin) remain statistically significant predictors for decreased CD62E+ to CD31+/annexin V+ ratio in MetS patients with CHF. In conclusion, decreased CD62E+ to CD31+/annexin V+ ratio reflected that impaired immune phenotype of MPs may be discussed as a surrogate marker of CHF development in MetS population.

Schlagwörter

Stichwörter der Autor:innen

Chronic heart failurecardiovascular risk factors inflammationcirculating microparticlesmetabolic syndromeneurohumoral activation

Autor:innen und Institutionen

  • Consultant of the Therapeutic Unit, Internal Medicine Department, State Medical University, Zaporozhye, Ukraine.
  • Private center Vita-Center, Zaporozhye, Ukraine.
  • Pathology Department, Dia-Service LTD, Zaporozhye, Ukraine.

Zitieren

APA

Berezin, A. E., Kremzer, A., Berezina, T., & Martovitskaya, Y. (2016). The signature of circulating microparticles in heart failure patients with metabolic syndrome. Journal of Circulating Biomarkers. https://doi.org/10.1177/1849454416663659

Vancouver

Berezin AE, Kremzer A, Berezina T, Martovitskaya Y. The signature of circulating microparticles in heart failure patients with metabolic syndrome. Journal of Circulating Biomarkers. 2016. doi:10.1177/1849454416663659

BibTeX
@article{Berezin2016,
  author = {Berezin, Alexander E and Kremzer, Alexander and Berezina, Tatyana and Martovitskaya, Yu},
  title = {The signature of circulating microparticles in heart failure patients with metabolic syndrome},
  journal = {Journal of Circulating Biomarkers},
  year = {2016},
  doi = {10.1177/1849454416663659}
}
Kostenlos starten →